http://purl.org/np/RACSiryP2eFJgDcSA8-CpxQzw4FZBXE9_TWPYGVLkQJsQ#Head http://purl.org/np/RACSiryP2eFJgDcSA8-CpxQzw4FZBXE9_TWPYGVLkQJsQ http://www.nanopub.org/nschema#hasAssertion http://purl.org/np/RACSiryP2eFJgDcSA8-CpxQzw4FZBXE9_TWPYGVLkQJsQ#assertion http://purl.org/np/RACSiryP2eFJgDcSA8-CpxQzw4FZBXE9_TWPYGVLkQJsQ http://www.nanopub.org/nschema#hasProvenance http://purl.org/np/RACSiryP2eFJgDcSA8-CpxQzw4FZBXE9_TWPYGVLkQJsQ#provenance http://purl.org/np/RACSiryP2eFJgDcSA8-CpxQzw4FZBXE9_TWPYGVLkQJsQ http://www.nanopub.org/nschema#hasPublicationInfo http://purl.org/np/RACSiryP2eFJgDcSA8-CpxQzw4FZBXE9_TWPYGVLkQJsQ#pubinfo http://purl.org/np/RACSiryP2eFJgDcSA8-CpxQzw4FZBXE9_TWPYGVLkQJsQ http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.nanopub.org/nschema#Nanopublication http://purl.org/np/RACSiryP2eFJgDcSA8-CpxQzw4FZBXE9_TWPYGVLkQJsQ#assertion http://purl.obolibrary.org/obo/DOID_9952 https://w3id.org/biolink/vocab/category https://w3id.org/biolink/vocab/Disease http://purl.org/np/RACSiryP2eFJgDcSA8-CpxQzw4FZBXE9_TWPYGVLkQJsQ#association http://www.w3.org/1999/02/22-rdf-syntax-ns#object http://purl.obolibrary.org/obo/DOID_9952 http://purl.org/np/RACSiryP2eFJgDcSA8-CpxQzw4FZBXE9_TWPYGVLkQJsQ#association http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate https://w3id.org/biolink/vocab/treats http://purl.org/np/RACSiryP2eFJgDcSA8-CpxQzw4FZBXE9_TWPYGVLkQJsQ#association http://www.w3.org/1999/02/22-rdf-syntax-ns#subject https://identifiers.org/drugbank:DB00059 http://purl.org/np/RACSiryP2eFJgDcSA8-CpxQzw4FZBXE9_TWPYGVLkQJsQ#association http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement http://purl.org/np/RACSiryP2eFJgDcSA8-CpxQzw4FZBXE9_TWPYGVLkQJsQ#association http://www.w3.org/2000/01/rdf-schema#label oncaspar is an asparagine specific enzyme indicated as a component of a multi agent chemotherapeutic regimen for treatment of pediatric and adult patients with first line acute lymphoblastic leukemia 1 1 acute lymphoblastic leukemia and hypersensitivity to asparaginase 1 2 oncaspar r is indicated as a component of a multi agent chemotherapeutic regimen for the first line treatment of pediatric and adult patients with all oncaspar is indicated as a component of a multi agent chemotherapeutic regimen for the treatment of pediatric and adult patients with all and hypersensitivity to native forms of l asparaginase http://purl.org/np/RACSiryP2eFJgDcSA8-CpxQzw4FZBXE9_TWPYGVLkQJsQ#association https://w3id.org/biolink/vocab/association_type https://w3id.org/biolink/vocab/ChemicalToDiseaseOrPhenotypicFeatureAssociation http://purl.org/np/RACSiryP2eFJgDcSA8-CpxQzw4FZBXE9_TWPYGVLkQJsQ#association https://w3id.org/biolink/vocab/provided_by https://w3id.org/um/NeuroDKG http://purl.org/np/RACSiryP2eFJgDcSA8-CpxQzw4FZBXE9_TWPYGVLkQJsQ#association https://w3id.org/biolink/vocab/relation https://schema.org/TreatmentIndication https://identifiers.org/drugbank:DB00059 https://w3id.org/biolink/vocab/category https://w3id.org/biolink/vocab/Drug http://purl.org/np/RACSiryP2eFJgDcSA8-CpxQzw4FZBXE9_TWPYGVLkQJsQ#provenance http://purl.org/np/RACSiryP2eFJgDcSA8-CpxQzw4FZBXE9_TWPYGVLkQJsQ#assertion http://www.w3.org/ns/prov#wasAttributedTo https://orcid.org/0000-0002-1468-3557 http://purl.org/np/RACSiryP2eFJgDcSA8-CpxQzw4FZBXE9_TWPYGVLkQJsQ#pubinfo http://purl.org/np/RACSiryP2eFJgDcSA8-CpxQzw4FZBXE9_TWPYGVLkQJsQ#sig http://purl.org/nanopub/x/hasAlgorithm RSA http://purl.org/np/RACSiryP2eFJgDcSA8-CpxQzw4FZBXE9_TWPYGVLkQJsQ#sig http://purl.org/nanopub/x/hasPublicKey MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB http://purl.org/np/RACSiryP2eFJgDcSA8-CpxQzw4FZBXE9_TWPYGVLkQJsQ#sig http://purl.org/nanopub/x/hasSignature TZrR6w1Cpf/xIAHUVwPWmXRixKQag+djOzVFYmGNmOvAko6/xuuaUEhuTG8qArVrOf+9HMXzXkj5y2J+Dbf2fBkhvbBjU6l8VTnP5nWrPY8d8idL7maLUXplRmgKHh6tcevRW9ow6Y6co1t2mbUg3dal82I800BMae2Dxg7Lj6E= http://purl.org/np/RACSiryP2eFJgDcSA8-CpxQzw4FZBXE9_TWPYGVLkQJsQ#sig http://purl.org/nanopub/x/hasSignatureTarget http://purl.org/np/RACSiryP2eFJgDcSA8-CpxQzw4FZBXE9_TWPYGVLkQJsQ http://purl.org/np/RACSiryP2eFJgDcSA8-CpxQzw4FZBXE9_TWPYGVLkQJsQ http://purl.org/dc/terms/created 2021-06-12T12:36:41.329+02:00 http://purl.org/np/RACSiryP2eFJgDcSA8-CpxQzw4FZBXE9_TWPYGVLkQJsQ http://purl.org/dc/terms/creator https://orcid.org/0000-0002-1468-3557 http://purl.org/np/RACSiryP2eFJgDcSA8-CpxQzw4FZBXE9_TWPYGVLkQJsQ https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM http://purl.org/np/RACSiryP2eFJgDcSA8-CpxQzw4FZBXE9_TWPYGVLkQJsQ https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM http://purl.org/np/RACSiryP2eFJgDcSA8-CpxQzw4FZBXE9_TWPYGVLkQJsQ https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate http://purl.org/np/RAManV5GZI01JKzW_IPcfOXoiFTcZMmsV7qTCLkdzr4Gs